INTRODUCTION: Polyethylene glycol-20k (PEG-20k) is highly effective for low-volume resuscitation (LVR) by increasing tolerance to the low-volume state. In our rodent shock model, PEG-20k increased survival and expanded the "golden hour" 16-fold compared to saline. The molecular mechanism is largely attributed to normalizations in cell and tissue fluid shifts after low-flow ischemia resulting in efficient microvascular exchange. The objective of this study was to evaluate PEG-20k as an LVR solution for hemorrhagic shock in a preclinical model. METHODS: Anesthetized male Yorkshire pigs (30-40 kg) were hemorrhaged to a mean arterial pressure (MAP) of 35 to 40 mm Hg. Once lactate reached 7 mmol/L, either saline (n = 5) or 10% PEG-20k (n = 5) was rapidly infused at 10% calculated blood volume. The primary outcome was LVR time, defined by the time from LVR administration to the time when lactate again reached 7 mmol/L. Other outcomes measured included MAP, heart rate, cardiac output, mixed venous oxygen saturation, splanchnic blood flow, and hemoglobin. RESULTS: Relative to saline, PEG-20k given after controlled hemorrhage increased LVR time by 16-fold, a conservative estimate given that the lactate never rose after LVR in the PEG-20k group. Survival was 80% for PEG-20k LVR compared to 0% for the saline controls (p < 0.05). Polyethylene glycol-20k also significantly decreased heart rate after hemorrhage and increased cardiac output, MAP, splanchnic flow, and mixed venous oxygen saturation. Falling hemoglobin concentrations suggested sizable hemodilution from fluid shifts into the intravascular compartment. CONCLUSIONS: In a preclinical model of controlled hemorrhagic shock, PEG-20k-based LVR solution increased tolerance to the shock state 16-fold compared to saline. Polyethylene glycol-20k is a superior crystalloid for LVR that may increase safe transport times in the prehospital setting and find use in hospital emergency departments and operating rooms for patients awaiting volume replacement or normalization of cell, tissue, and compartment fluid volumes.
INTRODUCTION:Polyethylene glycol-20k (PEG-20k) is highly effective for low-volume resuscitation (LVR) by increasing tolerance to the low-volume state. In our rodent shock model, PEG-20k increased survival and expanded the "golden hour" 16-fold compared to saline. The molecular mechanism is largely attributed to normalizations in cell and tissue fluid shifts after low-flow ischemia resulting in efficient microvascular exchange. The objective of this study was to evaluate PEG-20k as an LVR solution for hemorrhagic shock in a preclinical model. METHODS: Anesthetized male Yorkshire pigs (30-40 kg) were hemorrhaged to a mean arterial pressure (MAP) of 35 to 40 mm Hg. Once lactate reached 7 mmol/L, either saline (n = 5) or 10% PEG-20k (n = 5) was rapidly infused at 10% calculated blood volume. The primary outcome was LVR time, defined by the time from LVR administration to the time when lactate again reached 7 mmol/L. Other outcomes measured included MAP, heart rate, cardiac output, mixed venous oxygen saturation, splanchnic blood flow, and hemoglobin. RESULTS: Relative to saline, PEG-20k given after controlled hemorrhage increased LVR time by 16-fold, a conservative estimate given that the lactate never rose after LVR in the PEG-20k group. Survival was 80% for PEG-20k LVR compared to 0% for the saline controls (p < 0.05). Polyethylene glycol-20k also significantly decreased heart rate after hemorrhage and increased cardiac output, MAP, splanchnic flow, and mixed venous oxygen saturation. Falling hemoglobin concentrations suggested sizable hemodilution from fluid shifts into the intravascular compartment. CONCLUSIONS: In a preclinical model of controlled hemorrhagic shock, PEG-20k-based LVR solution increased tolerance to the shock state 16-fold compared to saline. Polyethylene glycol-20k is a superior crystalloid for LVR that may increase safe transport times in the prehospital setting and find use in hospital emergency departments and operating rooms for patients awaiting volume replacement or normalization of cell, tissue, and compartment fluid volumes.
Authors: Benjamin Leong; Penny S Reynolds; Mohamad H Tiba; William H Holbert; Gerard T Draucker; Juliana A Medina; Robert W Barbee; Nathan J White; Kevin R Ward Journal: Resuscitation Date: 2011-03-29 Impact factor: 5.262
Authors: Matthew J Delano; Sandro B Rizoli; Shawn G Rhind; Joseph Cuschieri; Wolfgang Junger; Andrew J Baker; Michael A Dubick; David B Hoyt; Eileen M Bulger Journal: Shock Date: 2015-07 Impact factor: 3.454
Authors: Eileen M Bulger; Susanne May; Jeffery D Kerby; Scott Emerson; Ian G Stiell; Martin A Schreiber; Karen J Brasel; Samuel A Tisherman; Raul Coimbra; Sandro Rizoli; Joseph P Minei; J Steven Hata; George Sopko; David C Evans; David B Hoyt Journal: Ann Surg Date: 2011-03 Impact factor: 12.969
Authors: Morgan D McSweeney; Lauren S L Price; Timothy Wessler; Elizabeth C Ciociola; Leah B Herity; Joseph A Piscitelli; Alexander C DeWalle; Taylor N Harris; Andy K P Chan; Ran Sing Saw; Peiqi Hu; J Charles Jennette; M Gregory Forest; Yanguang Cao; Stephanie A Montgomery; William C Zamboni; Samuel K Lai Journal: J Control Release Date: 2019-08-24 Impact factor: 9.776
Authors: Lian Liang; Guozhen Zhang; Hui Li; Cheng Cheng; Tao Jin; Chenglei Su; Yan Xiao; Jennifer Bradley; Mary A Peberdy; Joseph P Ornato; Martin J Mangino; Wanchun Tang Journal: J Am Heart Assoc Date: 2021-04-22 Impact factor: 5.501
Authors: Loren K Liebrecht; Jason Newton; Erika J Martin; Nina Wickramaratne; Sudha Jayaraman; Jinfeng Han; Michel Aboutanos; Donald F Brophy; Martin J Mangino Journal: PLoS One Date: 2018-11-15 Impact factor: 3.240
Authors: Loren K Liebrecht; Jason Newton; Erika J Martin; Niluka Wickramaratne; Sudha Jayaraman; Jinfeng Han; Michel Aboutanos; Donald F Brophy; Martin J Mangino Journal: PLoS One Date: 2019-05-01 Impact factor: 3.240